- You are viewing a Navigating Care library resource.
- Go to Library
To Learn More About Chronic Myelogenous Leukemia
For more information from the National Cancer Institute about chronic myelogenous leukemia, see the following:
- Leukemia Home Page
- Targeted Therapy to Treat Cancer
- Drugs Approved for Chronic Myelogenous Leukemia
- Drugs Approved for Myeloproliferative Neoplasms
- Immunotherapy to Treat Cancer
- Stem Cell Transplants to Treat Cancer
For general cancer information and other resources from the National Cancer Institute, visit:
- About Cancer
- Staging
- Chemotherapy and You: Support for People With Cancer
- Radiation Therapy and You: Support for People With Cancer
- Coping with Cancer
- Questions to Ask Your Doctor about Cancer
- For Survivors and Caregivers
This information is not intended to replace the advice of a doctor.
Navigating Care disclaims any liability for the decisions you make based on this information.
This information was sourced and adapted from Adapted from the National Cancer Institute's
Physician Data Query (PDQ®) Cancer Information Summaries on
www.cancer.gov.
This information updated
October 1, 2024.
Learn more:
- General Information About Chronic Myelogenous Leukemia
- Stages of Chronic Myelogenous Leukemia
- Treatment Option Overview
- Treatment of Chronic Phase Chronic Myelogenous Leukemia
- Treatment of Accelerated Phase Chronic Myelogenous Leukemia
- Treatment of Blastic Phase Chronic Myelogenous Leukemia
- Treatment of Relapsed Chronic Myelogenous Leukemia
- To Learn More About Chronic Myelogenous Leukemia
Related Articles
- General Information About Chronic Myelogenous Leukemia
- Stages of Chronic Myelogenous Leukemia
- Treatment Option Overview
- Treatment of Chronic Phase Chronic Myelogenous Leukemia
- Treatment of Accelerated Phase Chronic Myelogenous Leukemia
- Treatment of Blastic Phase Chronic Myelogenous Leukemia
- Treatment of Relapsed Chronic Myelogenous Leukemia
- To Learn More About Chronic Myelogenous Leukemia
See Expert Resources
The Navigating Care Library includes articles about cancer, chemotherapy regimens and drugs from the
the National Cancer Institute and other experts.